ArticleNucleic acids research2023

Rarely acquired type II-A CRISPR-Cas spacers mediate anti-viral immunity through the targeting of a non-canonical PAM sequence.

Claire T Kenney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.